| pubmed-article:10227514 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10227514 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:10227514 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
| pubmed-article:10227514 | lifeskim:mentions | umls-concept:C0000726 | lld:lifeskim |
| pubmed-article:10227514 | lifeskim:mentions | umls-concept:C0030797 | lld:lifeskim |
| pubmed-article:10227514 | lifeskim:mentions | umls-concept:C0024219 | lld:lifeskim |
| pubmed-article:10227514 | lifeskim:mentions | umls-concept:C1707520 | lld:lifeskim |
| pubmed-article:10227514 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:10227514 | lifeskim:mentions | umls-concept:C0386370 | lld:lifeskim |
| pubmed-article:10227514 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:10227514 | pubmed:dateCreated | 1999-5-17 | lld:pubmed |
| pubmed-article:10227514 | pubmed:abstractText | The purpose of this study was to administer ultrasmall superparamagnetic iron oxide (USPIO) and compare changes in signal intensity of lymph nodes in patients with primary abdominal and pelvic malignancies. Also, we correlated radiographic with pathologic findings. | lld:pubmed |
| pubmed-article:10227514 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10227514 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10227514 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:10227514 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10227514 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10227514 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10227514 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10227514 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10227514 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10227514 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10227514 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10227514 | pubmed:month | May | lld:pubmed |
| pubmed-article:10227514 | pubmed:issn | 0361-803X | lld:pubmed |
| pubmed-article:10227514 | pubmed:author | pubmed-author:WoodB JBJ | lld:pubmed |
| pubmed-article:10227514 | pubmed:author | pubmed-author:SainoYY | lld:pubmed |
| pubmed-article:10227514 | pubmed:author | pubmed-author:HahnP FPF | lld:pubmed |
| pubmed-article:10227514 | pubmed:author | pubmed-author:MuellerP RPR | lld:pubmed |
| pubmed-article:10227514 | pubmed:author | pubmed-author:TempanyCC | lld:pubmed |
| pubmed-article:10227514 | pubmed:author | pubmed-author:WeisslederRR | lld:pubmed |
| pubmed-article:10227514 | pubmed:author | pubmed-author:HarisinghaniM... | lld:pubmed |
| pubmed-article:10227514 | pubmed:author | pubmed-author:YantissR KRK | lld:pubmed |
| pubmed-article:10227514 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10227514 | pubmed:volume | 172 | lld:pubmed |
| pubmed-article:10227514 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10227514 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10227514 | pubmed:pagination | 1347-51 | lld:pubmed |
| pubmed-article:10227514 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:10227514 | pubmed:meshHeading | pubmed-meshheading:10227514... | lld:pubmed |
| pubmed-article:10227514 | pubmed:meshHeading | pubmed-meshheading:10227514... | lld:pubmed |
| pubmed-article:10227514 | pubmed:meshHeading | pubmed-meshheading:10227514... | lld:pubmed |
| pubmed-article:10227514 | pubmed:meshHeading | pubmed-meshheading:10227514... | lld:pubmed |
| pubmed-article:10227514 | pubmed:meshHeading | pubmed-meshheading:10227514... | lld:pubmed |
| pubmed-article:10227514 | pubmed:meshHeading | pubmed-meshheading:10227514... | lld:pubmed |
| pubmed-article:10227514 | pubmed:meshHeading | pubmed-meshheading:10227514... | lld:pubmed |
| pubmed-article:10227514 | pubmed:meshHeading | pubmed-meshheading:10227514... | lld:pubmed |
| pubmed-article:10227514 | pubmed:meshHeading | pubmed-meshheading:10227514... | lld:pubmed |
| pubmed-article:10227514 | pubmed:meshHeading | pubmed-meshheading:10227514... | lld:pubmed |
| pubmed-article:10227514 | pubmed:meshHeading | pubmed-meshheading:10227514... | lld:pubmed |
| pubmed-article:10227514 | pubmed:meshHeading | pubmed-meshheading:10227514... | lld:pubmed |
| pubmed-article:10227514 | pubmed:meshHeading | pubmed-meshheading:10227514... | lld:pubmed |
| pubmed-article:10227514 | pubmed:meshHeading | pubmed-meshheading:10227514... | lld:pubmed |
| pubmed-article:10227514 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10227514 | pubmed:articleTitle | MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation. | lld:pubmed |
| pubmed-article:10227514 | pubmed:affiliation | Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA. | lld:pubmed |
| pubmed-article:10227514 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10227514 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10227514 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:10227514 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| pubmed-article:10227514 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10227514 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10227514 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10227514 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10227514 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10227514 | lld:pubmed |
